Q6FPT1

PR
Gene name
ATP25 (CAGL0J01199g)
Protein name
ATPase synthesis protein 25, mitochondrial
Names
Species
Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)
KEGG Pathway
cgr:CAGL0J01199g
EC number
Protein Class

Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

36-143 (Predicted disordered autoinhibitory region) PR

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for Q6FPT1

Entry ID Method Resolution Chain Position Source
AF-Q6FPT1-F1 Predicted AlphaFoldDB

No variants for Q6FPT1

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6FPT1

No associated diseases with Q6FPT1

1 regional properties for Q6FPT1

Type Name Position InterPro Accession
domain ATP25 mRNA stabilisation domain 321 - 601 IPR025210

Functions

Description
EC Number
Subcellular Localization
  • Mitochondrion inner membrane ; Peripheral membrane protein ; Matrix side
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
mitochondrial inner membrane The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

2 GO annotations of biological process

Name Definition
mitochondrial gene expression The process in which a mitochondrial gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
mRNA stabilization Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MQSLLQLKHY PLLTSYLEVL STQKLHYMLR IRSIARPIVR RPWANAARVT GISGTRIQVP
70 80 90 100 110 120
FPSSVRWYSD REPQTEPVVK DEESEHVPWY MRLEDDSLKS LNEDISKQHE VRLPDDCPDS
130 140 150 160 170 180
LHILVKHLQK QLALRDILVF DLKNQRLADP ENYRLKMCDY VIICTAMSTK HCERSYVEIN
190 200 210 220 230 240
KLLKNEYGVS GYVEGQVNPN DEKKRLKRLA RKNNLGRTNI RRNALNSTEE SSWYMIDCHV
250 260 270 280 290 300
DSIFLNILTE NRRYEMNLEE LYAPLNEKHL YEKSEHSMHI NTNNRSQAFD SLEEEDNVLL
310 320 330 340 350 360
ALRKLAQQKR QYSTESPARS LRNELVKENF DSSKKLLADN PELREQLVKV AISTIEQIRD
370 380 390 400 410 420
STGASINTEK WYKFVSHNVP LVIQDTTFWD SYLKFLLLLN DCNSQTYSYK RLIPDYLVTK
430 440 450 460 470 480
RSMGEELTAD DITTFLSVIS ERVNPQNYWD LVKANTQVVE ALRLFDEEVI FTDAILSKVI
490 500 510 520 530 540
KTLTTNSNEH KLHSFYEVIK FLVWKYEKEI PINTLETILK TLINFGEYDY LLRLWTTKIG
550 560 570 580 590 600
YNVGSKDTRP WKVFLKAITE TQDVELIRLI IEKGCLLDIS RGKVDVDPQL AVLLKTAFKT
610 620
VDPENLIYND QQRLLIPSSA TRQ